This company has been marked as potentially delisted and may not be actively trading. Freeline Therapeutics (FRLN) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Freeline Therapeutics Short Interest DataFreeline Therapeutics (FRLN) has a short interest of 23,900 shares, representing 0.58% of the float (the number of shares available for trading by the public). This marks a -15.55% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 12,055 shares to cover all short positions.Current Short Interest23,900 sharesPrevious Short Interest28,300 sharesChange Vs. Previous Month-15.55%Dollar Volume Sold Short$153.92 thousandShort Interest Ratio0.6 Days to CoverLast Record DateJanuary 31, 2024Outstanding Shares4,340,000 sharesFloat Size4,140,000 sharesShort Percent of Float0.58%Today's Trading Volume0 sharesAverage Trading Volume12,055 sharesToday's Volume Vs. Average0% Short Selling Freeline Therapeutics? Sign up to receive the latest short interest report for Freeline Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFRLN Short Interest Over TimeFRLN Days to Cover Over TimeFRLN Percentage of Float Shorted Over Time Freeline Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202423,900 shares $153.92 thousand -15.6%0.6%0.6 $6.44 1/15/202428,300 shares $180.84 thousand -41.0%0.7%0.6 $6.39 12/31/202348,000 shares $305.76 thousand -6.6%1.2%0.7 $6.37 12/15/202351,400 shares $332.04 thousand -35.4%1.2%0.2 $6.46 11/30/202379,500 shares $501.65 thousand -21.8%1.9%0.4 $6.31 11/15/2023101,700 shares $492.23 thousand -28.5%2.5%0.5 $4.84 10/31/2023142,300 shares $712.92 thousand -46.8%3.4%0.7 $5.01 10/15/2023267,500 shares $971.03 thousand +164.9%6.5%1.3 $3.63 9/30/2023101,000 shares $434.30 thousand -2.2%2.4%0.2 $4.30 9/15/2023103,300 shares $387.38 thousand -2.5%2.5%0.3 $3.75 Get the Latest News and Ratings for FRLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Freeline Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2023105,900 shares $379.12 thousand -17.1%2.6%0.3 $3.58 8/15/2023127,800 shares $493.31 thousand +22.3%3.1%0.3 $3.86 7/31/2023104,500 shares $379.34 thousand -69.7%2.5%0.2 $3.63 7/15/2023345,200 shares $1.94 million +1,164.5%8.4%0.8 $5.63 6/30/202327,300 shares $70.43 thousand -50.7%0.7%0.1 $2.58 6/15/202355,400 shares $148.47 thousand +93.7%1.3%0.5 $2.68 5/31/202328,600 shares $71.79 thousand +271.4%0.7%0.3 $2.51 5/15/20237,700 shares $25.64 thousand No Change0.2%0.1 $3.33 10/31/2022147,500 shares $107.67 thousand +7.8%N/A4.6 $0.73 10/15/2022136,800 shares $90.29 thousand -2.5%N/A3.4 $0.66 9/30/2022140,300 shares $98.21 thousand -10.2%N/A2.2 $0.70 9/15/2022156,200 shares $133.05 thousand -3.4%N/A2 $0.85 8/31/2022161,700 shares $137.36 thousand -1.6%N/A2 $0.85 8/15/2022164,300 shares $161.01 thousand -27.9%N/A2 $0.98 7/31/2022227,800 shares $202.74 thousand +11.4%N/A2.7 $0.89 7/15/2022204,500 shares $156.91 thousand -3.4%N/A2.2 $0.77 6/30/2022211,700 shares $184.18 thousand -7.8%N/A1.6 $0.87 6/15/2022229,500 shares $189.31 thousand -15.1%N/A1.2 $0.82 5/31/2022270,300 shares $208.10 thousand +11.8%N/A1.4 $0.77 5/15/2022241,700 shares $181.28 thousand -18.3%1.0%1.2 $0.75 4/30/2022295,700 shares $266.16 thousand +8.5%2.5%1.4 $0.90 4/15/2022272,600 shares $278.05 thousand -20.9%2.3%1.1 $1.02 3/31/2022344,400 shares $385.73 thousand +41.4%N/A1.1 $1.12 3/15/2022243,500 shares $227.19 thousand +2.2%0.7%0.3 $0.93 2/28/2022238,200 shares $252.49 thousand +3.2%0.7%0.3 $1.06 2/15/2022230,800 shares $281.58 thousand -7.5%0.7%0.3 $1.22 1/31/2022249,600 shares $309.50 thousand -20.3%0.8%0.3 $1.24 1/15/2022313,300 shares $460.55 thousand +249.7%N/A0.3 $1.47 12/31/202189,600 shares $177.41 thousand +93.1%0.3%0.1 $1.98 12/15/202146,400 shares $100.69 thousand +16.3%0.1%0.5 $2.17Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 11/30/202139,900 shares $92.57 thousand -8.9%0.1%0.3 $2.32 11/15/202143,800 shares $130.52 thousand -33.3%0.1%0.3 $2.98 10/29/202165,700 shares $195.79 thousand +3.0%0.2%0.2 $2.98 10/15/202163,800 shares $204.80 thousand -15.2%0.2%0.2 $3.21 9/30/202175,200 shares $256.43 thousand +5.0%0.2%0.2 $3.41 9/15/202171,600 shares $284.25 thousand -7.1%0.2%0.2 $3.97 8/31/202177,100 shares $296.84 thousand -18.2%0.2%0.2 $3.85 8/13/202194,200 shares $312.74 thousand +3.3%0.3%0.2 $3.32 7/30/202191,200 shares $434.11 thousand +165.1%0.3%0.4 $4.76 7/15/202134,400 shares $227.38 thousand -37.3%0.1%0.3 $6.61 6/30/202154,900 shares $447.44 thousand +10.9%0.2%1.6 $8.15 6/15/202149,500 shares $470.75 thousand -24.2%0.2%1.6 $9.51 5/28/202165,300 shares $718.30 thousand +25.6%0.2%2.4 $11.00 5/14/202152,000 shares $455 thousand +83.8%0.2%4.3 $8.75 4/30/202128,300 shares $332.81 thousand -5.0%0.1%2.7 $11.76 4/15/202129,800 shares $359.09 thousand +1.0%N/A0 $12.05 3/31/202129,500 shares $392.06 thousand -9.0%0.1%3.3 $13.29 3/15/202132,400 shares $456.52 thousand +7.3%0.1%3.4 $14.09 2/26/202130,200 shares $456.93 thousand +6.3%0.1%2.5 $15.13 2/12/202128,400 shares $429.41 thousand -8.4%0.1%2.3 $15.12 1/29/202131,000 shares $550.25 thousand -61.1%0.1%2.1 $17.75 1/15/202179,700 shares $1.43 million No Change0.2%4.9 $18.00 FRLN Short Interest - Frequently Asked Questions What is Freeline Therapeutics' current short interest? Short interest is the volume of Freeline Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 23,900 shares of FRLN short. 0.58% of Freeline Therapeutics' shares are currently sold short. Learn More on Freeline Therapeutics' current short interest. What is a good short interest ratio for Freeline Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FRLN shares currently have a short interest ratio of 1.0. Learn More on Freeline Therapeutics's short interest ratio. What is a good short interest percentage for Freeline Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of Freeline Therapeutics' floating shares are currently sold short. Is Freeline Therapeutics' short interest increasing or decreasing? Freeline Therapeutics saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 23,900 shares, a decrease of 15.5% from the previous total of 28,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Freeline Therapeutics' float size? Freeline Therapeutics currently has issued a total of 4,340,000 shares. Some of Freeline Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Freeline Therapeutics currently has a public float of 4,140,000 shares. How does Freeline Therapeutics' short interest compare to its competitors? 0.58% of Freeline Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Freeline Therapeutics: Kaleido Biosciences, Inc. (0.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors Company ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Corporation ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply Company ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Freeline Therapeutics stock? Short selling FRLN is an investing strategy that aims to generate trading profit from Freeline Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Freeline Therapeutics? A short squeeze for Freeline Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FRLN, which in turn drives the price of the stock up even further. How often is Freeline Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FRLN, twice per month. The most recent reporting period available is January, 31 2024. More Short Interest Resources from MarketBeat Related Companies KLDO Short Interest Data APLMW Short Interest Data BCTXW Short Interest Data CDIOW Short Interest Data CEROW Short Interest Data CLNNW Short Interest Data CMRAW Short Interest Data CDTTW Short Interest Data EFTRW Short Interest Data ENGNW Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FRLN) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Freeline Therapeutics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Freeline Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.